Biocon's net profit doubles to Rs 172.7 crore in Q2 : vimars

Indian pharmaceutical giant Biocon on Friday reported a net profit of Rs 172.7 crore in the September quarter of financial year 2023-24, more than double its profit of Rs 81.8 crore in the same period of the previous year.According to the ...

Related Keywords

Australia , Japan , New Zealand , Bengaluru , Karnataka , India , United States , America , American , Biocon Biologics , Jonathan Hunt , Shreehas Tambe , Siddharth Mittal , Biocon Biologics Ltd , Biocon , Manufacturing Services , Biocon Ltd , North America , Emerging Markets , Managing Director Siddharth Mittal , North American , Generic Formulations , Managing Director Shreehas Tambe , Managing Director Jonathan Hunt , Quality Control ,